Literature DB >> 9533656

Induction of HIV-1 replication by type 1-like cytokines, interleukin (IL)-12 and IL-15: effect on viral transcriptional activation, cellular proliferation, and endogenous cytokine production.

L Al-Harthi1, K A Roebuck, A Landay.   

Abstract

Cytokine dysregulation is evident in HIV-1 infection and it may play an important role in HIV-1 pathogenesis. Administration of T helper cytokines potentially may restore the functional abnormalities to the HIV-1 immune response. Type 1-like cytokines, IL-2, IL-12, and IL-15, are candidates for immune-based therapy for HIV. Given their potential therapeutic use, we determined the effects of IL-2, IL-12, and IL-15 on HIV-1 replication in both primary blood mononuclear cells (PBMC) and the T-cell line, Kit 225-K6. We demonstrate that both IL-2 and IL-12 induce a similar level of HIV-1 replication (9- and 11-fold, respectively) in mitogen-stimulated PBMC. The effect of IL-2 plateaued by day 6, while that of IL-12 continued to increase HIV-1 expression. IL-15 induced a 2.5-fold increase in HIV-1 expression that remained at the same level through day 6. In Kit 225-K6, an IL-2-dependent T cell line, IL-12 and IL-15 enhanced HIV-1 replication by 5- and 3.5-fold over IL-2-treated cultures, respectively. IL-2-, IL-12-, and IL-15-mediated induction of HIV was independent of direct HIV-1 LTR activation, since none of the cytokines induced LTR activity from transfected reporter gene constructs. The cytokine-mediated induction of HIV-1 expression was also independent of cellular proliferation. In PBMC, the IL-12-mediated effect was partially mediated by endogenous cytokine production of IL-1beta and IL-7, whereas in Kit 225-K6, TNFalpha, INFgamma, IL-1beta, and IL-7 did not contribute significantly to the IL-12-mediated effect. IL-15 effect on HIV-1 in PBMC was independent of endogenous cytokine production. However, in Kit 225-K6, neutralizing antibodies to IL-7 had a significant effect on HIV-1 expression. These data suggest that IL-2, IL-12, and IL-15 increase HIV-1 replication predominantly through a posttranscriptional mechanism that may be enhanced by endogenous cytokine production.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9533656     DOI: 10.1023/a:1023246800353

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  44 in total

Review 1.  Immunological effects of antiretroviral and immune therapies for HIV.

Authors:  A D Kelleher; L Al-Harthi; A L Landay
Journal:  AIDS       Date:  1997       Impact factor: 4.177

2.  Effect of interleukin-1 on the augmentation of human immunodeficiency virus gene expression.

Authors:  N Kobayashi; Y Hamamoto; Y Koyanagi; I S Chen; N Yamamoto
Journal:  Biochem Biophys Res Commun       Date:  1989-12-15       Impact factor: 3.575

3.  Production of tumour necrosis factor-alpha (TNF-alpha) and interleukin-1 (IL-1) in patients with AIDS. Enhanced level of TNF-alpha is related to a higher cytotoxic activity.

Authors:  D Hober; A Haque; P Wattre; G Beaucaire; Y Mouton; A Capron
Journal:  Clin Exp Immunol       Date:  1989-12       Impact factor: 4.330

4.  Subcutaneous administration of interleukin-2 in human immunodeficiency virus type 1-infected persons.

Authors:  R T Davey; D G Chaitt; S C Piscitelli; M Wells; J A Kovacs; R E Walker; J Falloon; M A Polis; J A Metcalf; H Masur; G Fyfe; H C Lane
Journal:  J Infect Dis       Date:  1997-04       Impact factor: 5.226

5.  Effects of TH1 and TH2 cytokines on CD8+ cell response against human immunodeficiency virus: implications for long-term survival.

Authors:  E Barker; C E Mackewicz; J A Levy
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-21       Impact factor: 11.205

6.  Interleukin 2 induces CD8+ T cell-mediated suppression of human immunodeficiency virus replication in CD4+ T cells and this effect overrides its ability to stimulate virus expression.

Authors:  A L Kinter; S M Bende; E C Hardy; R Jackson; A S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-21       Impact factor: 11.205

7.  Increases in CD4 T lymphocytes with intermittent courses of interleukin-2 in patients with human immunodeficiency virus infection. A preliminary study.

Authors:  J A Kovacs; M Baseler; R J Dewar; S Vogel; R T Davey; J Falloon; M A Polis; R E Walker; R Stevens; N P Salzman; Lane H. Clifford
Journal:  N Engl J Med       Date:  1995-03-02       Impact factor: 91.245

8.  Use of interleukin-2 in patients with acquired immunodeficiency syndrome.

Authors:  H C Lane; J P Siegel; A H Rook; H Masur; E P Gelmann; G V Quinnan; A S Fauci
Journal:  J Biol Response Mod       Date:  1984-10

9.  Efficacy of low doses of the polyethylene glycol derivative of interleukin-2 in modulating the immune response of patients with human immunodeficiency virus type 1 infection.

Authors:  H Teppler; G Kaplan; K Smith; P Cameron; A Montana; P Meyn; Z Cohn
Journal:  J Infect Dis       Date:  1993-02       Impact factor: 5.226

10.  Natural killer (NK) cell stimulatory factor increases the cytotoxic activity of NK cells from both healthy donors and human immunodeficiency virus-infected patients.

Authors:  J Chehimi; S E Starr; I Frank; M Rengaraju; S J Jackson; C Llanes; M Kobayashi; B Perussia; D Young; E Nickbarg
Journal:  J Exp Med       Date:  1992-03-01       Impact factor: 14.307

View more
  16 in total

1.  Mice transgenic for a soluble form of murine cytotoxic T lymphocyte antigen 4 are refractory to murine acquired immune deficiency sydrome development.

Authors:  L De Leval; S Debrus; P Lane; J Boniver; M Moutschen
Journal:  Immunology       Date:  1999-12       Impact factor: 7.397

2.  Long-term control of simian immunodeficiency virus (SIV) in cynomolgus macaques not associated with efficient SIV-specific CD8+ T-cell responses.

Authors:  Timothée Bruel; Chiraz Hamimi; Nathalie Dereuddre-Bosquet; Antonio Cosma; So Youn Shin; Aurélien Corneau; Pierre Versmisse; Ingrid Karlsson; Benoit Malleret; Brice Targat; Françoise Barré-Sinoussi; Roger Le Grand; Gianfranco Pancino; Asier Sáez-Cirión; Bruno Vaslin
Journal:  J Virol       Date:  2015-01-14       Impact factor: 5.103

Review 3.  Innate and adaptive factors regulating human immunodeficiency virus type 1 genomic activation.

Authors:  Sonia Shah; Michael R Nonnemacher; Vanessa Pirrone; Brian Wigdahl
Journal:  J Neuroimmune Pharmacol       Date:  2010-04-13       Impact factor: 4.147

4.  Interleukin-15 increases effector memory CD8+ t cells and NK Cells in simian immunodeficiency virus-infected macaques.

Authors:  Yvonne M Mueller; Constantinos Petrovas; Paul M Bojczuk; Ioannis D Dimitriou; Brigitte Beer; Peter Silvera; Francois Villinger; J Scott Cairns; Edward J Gracely; Mark G Lewis; Peter D Katsikis
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

5.  Gamma interferon primes productive human immunodeficiency virus infection in astrocytes.

Authors:  Deborah Carroll-Anzinger; Lena Al-Harthi
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

6.  Regulation of bovine leukemia virus tax and pol mRNA levels by interleukin-2 and -10.

Authors:  D Pyeon; G A Splitter
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

7.  Effect of interleukin (IL)-12 and IL-15 on activated natural killer (ANK) and antibody-dependent cellular cytotoxicity (ADCC) in HIV infection.

Authors:  S J Lin; R L Roberts; B J Ank; Q H Nguyen; E K Thomas; E R Stiehm
Journal:  J Clin Immunol       Date:  1998-09       Impact factor: 8.317

Review 8.  The role of cytokines in the establishment, persistence and eradication of the HIV reservoir.

Authors:  Claire Vandergeeten; Rémi Fromentin; Nicolas Chomont
Journal:  Cytokine Growth Factor Rev       Date:  2012-06-27       Impact factor: 7.638

9.  IL-15 treatment during acute simian immunodeficiency virus (SIV) infection increases viral set point and accelerates disease progression despite the induction of stronger SIV-specific CD8+ T cell responses.

Authors:  Yvonne M Mueller; Duc H Do; Susan R Altork; Carol M Artlett; Edward J Gracely; Christos D Katsetos; Agustin Legido; Francois Villinger; John D Altman; Charles R Brown; Mark G Lewis; Peter D Katsikis
Journal:  J Immunol       Date:  2008-01-01       Impact factor: 5.422

10.  Increased IL-15 production is associated with higher susceptibility of memory CD4 T cells to simian immunodeficiency virus during acute infection.

Authors:  Matthew D Eberly; Muhamuda Kader; Wail Hassan; Kenneth A Rogers; Jianzhong Zhou; Yvonne M Mueller; Mary J Mattapallil; Michael Piatak; Jeffrey D Lifson; Peter D Katsikis; Mario Roederer; Francois Villinger; Joseph J Mattapallil
Journal:  J Immunol       Date:  2009-02-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.